Research by a Michigan State University chemist could eventually lead to a quicker and easier way of developing protein-based drugs which are key to treating a number of diseases, including cancer, diabetes and hepatitis. Proteins used in drug manufacture and research often are made within genetically modified Escherichia coli, a one-cell bacteria. That protein tends to collect into what scientists call inclusion bodies. Those hard-to-separate clumps render up to 95 percent of the protein. (source: news.msu.edu)
|
